Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘elsevier’ Category

Quick: What does fish food have to do with X-rays? In this case, an Elsevier production error

without comments

An MRI of a fish, not involved in this study. (via Wikimedia)

In 2012, a study claiming to show — after some intentional statistical tricks — that a dead salmon had brain activity in an fMRI won a prestigious (and hilarious) Ig Nobel Prize.

So five years later, when Bálint Botz tweeted wryly about a study of fish and plants in a radiology journal, we thought, “Aha, someone is trying to create another red herring!”

But alas, it turns out the reason a journal normally concerned with X-rays would suddenly be interested in aquaponics was far more prosaic: Read the rest of this entry »

Written by Ivan Oransky

June 13th, 2017 at 11:30 am

Drug researcher up to ten retractions

without comments

A pharmaceutical researcher has received his tenth retraction. The reason, once again: duplicating his previous work.

Giuseppe Derosa, based at the University of Pavia in Italy, lost a 2011 paper this month after journal editors identified “substantial duplication of an earlier published paper.” According to the notice, the authors failed to cite the previous work and to disclose that the manuscript had been published or was under consideration elsewhere.

Derosa has a habit of reusing clinical trial data in multiple papers. He received his first four retractions in 2015 for publishing the same clinical trial results six times—two of those papers were retracted over the summer and two more several months later. By 2016, a fifth from the bunch was retracted (one of the six still stands). Derosa received another retraction, citing duplication (which we covered here and which was not related to the six clinical trials).

Read the rest of this entry »

Journal retracts nine papers in one day by author under investigation at the Weizmann Institute

with 3 comments

On April 27, the Journal of Biological Chemistry (JBC) retracted nine papers by a researcher based in Israel, including some dating back to 2000.

The reason: Image manipulation.

Michal Neeman, vice president of The Weizmann Institute of Science, told us that the researcher, Rony Seger, is under investigation following an allegation of misconduct affecting papers in multiple journals.

So far, we’ve found 11 retractions for papers by Seger, a molecular biologist. In the notices, the authors state they have “full confidence” in the findings, and in many instances have replicated the work.

According to Neeman:

Read the rest of this entry »

Journal retracts paper eight months after U.S. Feds announce findings of misconduct

without comments

In August, the U.S. Office of Research Integrity announced that a former postdoctoral fellow at the National Human Genome Research Institute (NHGRI) doctored data in two published papers.

It took one journal a little longer than five months to remove the researcher’s name from the co-author list, and replace one figure.

It took the second journal more than eight months to retract the paper.

Here’s the notice for “A BLOC-1 Mutation Screen Reveals that PLDN Is Mutated in Hermansky-Pudlak Syndrome Type 9,” published by the American Journal of Human Genetics (AJHG):

Read the rest of this entry »

Despite author’s protest, journal removes paper on emergency department prices

without comments

A journal has temporarily removed a paper showing the dramatic differences in the cost of providing emergency care that caught national attention (and some criticism from emergency care providers), despite the first author’s claims that the results are valid.

The paper, published online in February by the Annals of Emergency Medicine, showed that it can cost significantly more for patients to be treated at emergency departments than at urgent care centers, even for the same conditions. Soon after the paper was published, first author Vivian Ho at Rice University was told by the American College of Emergency Physicians, which publishes the journal, that there were some errors in the appendix, and they wanted to reanalyze the entire paper.

Ho told us:

Read the rest of this entry »

A university asked for numerous retractions. Eight months later, three journals have done nothing.

with 8 comments

Anil Jaiswal

When journals learn papers are problematic, how long does it take them to act?

We recently had a chance to find out as part of our continuing coverage of the case of Anil Jaiswal at the University of Maryland, who’s retracted 15 papers (including two new ones we recently identified), and has transitioned out of cancer research. Here’s what happened.

As part of a public records request related to the investigation, we received letters that the University of Maryland sent to 11 journals regarding 26 “compromised” papers co-authored by Jaiswal, four of which had been retracted by the time of the letter. The letters were dated between August and September 2016 (and one in February) — although, in some cases, the journals told us they received the letter later. Since that date, three journals have retracted nine papers and corrected another, waiting between four and six months to take action. One journal published an editorial note of concern within approximately two months after the university letter.

And six journals have not taken any public action.

Read the rest of this entry »

A shadow was cast on a bone researcher’s work. What are journals doing about his papers?

with one comment

Last year, a researcher cast doubt on a bone scientist’s clinical trials, suggesting some of the findings may not be legitimate. So what’s happened since?

Since 2015, journals have retracted 14 papers by bone researcher Yoshihiro Sato, based at Mitate Hospital in Japan, for issues ranging from self-plagiarism, to problems with data, to including co-authors without their consent. (We covered the latest two retractions this week.) Last year’s analysis identified patterns in more than 30 of Sato’s clinical trials that suggest systematic problems with the results. (Sato has defended his research.)

With doubts cast on Sato’s body of work, we contacted the journals that have published his papers involving human trials, to see if any taken another look at Sato’s work; several responded. While most believe there is little reason to take further action at this time, some told us they are investigating.
Read the rest of this entry »

Prominent physicist loses four more papers for duplication

with one comment

A leading physicist in India has lost four more papers for duplication, after colleagues lodged a complaint against him.

According to the most recent retraction notices, issued by Applied Surface Science, the four papers duplicated several figures and portions of text from the authors’ previous works. Although the notices do not single out a responsible party, last year the Mumbai Mirror reported that first and corresponding Naba K. Sahoo had been accused of duplication by colleagues at the Bhabha Atomic Research Centre (BARC), part of Indian government’s Department of Atomic Energy.

(In a bizarre twist, Sahoo also made the news recently for getting into a fist fight with another BARC scientist.)

Sahoo received two retractions last year for duplication, sometimes inelegantly referred to as “self-plagiarism.” All six of his retractions affect papers published by Applied Surface Science between 2005 and 2007.

The first retraction notice explains that a 2006 paper lifted portions of text from an earlier paper by Sahoo: Read the rest of this entry »

Busted: Researcher used fake contact info for co-authors

without comments

In February, Lusine Abrahamyan, an assistant professor at the University of Toronto, was contacted by ResearchGate. Her name was listed on a 2016 paper in a heart journal, the site told her — was Abrahamyan indeed a co-author?

Um, no, she was not. In fact, before that moment, she didn’t know such a paper existed.

It turns out, Abrahamyan had supervised the thesis of the first author — who, she soon learned, had also published an identical paper in another heart journal. Both have since been retracted.

How did this happen?

International Cardiovascular Forum Journal editor Andrew Coats told us more about the actions of first author Joshua Chadwick Jayaraj: Read the rest of this entry »

Idea theft: Two food chemistry papers retracted for using someone’s ideas

without comments

A researcher has retracted two papers after her former supervisor complained she had used his ideas and methodology.

In addition, some of the work was apparently covered by a copyright agreement.

Both papers were co-authored by the same three people. The idea theft came to light after one of the co-authors received a complaint from her former supervisor, prompting her to contact the publisher to resolve the issue.

Wendy Hurp, executive publisher of Food Science at Elsevier, which publishes the two journals, provided some additional background on what happened: Read the rest of this entry »